Mölnlycke Health Care, owned by the investment company Investor, has announced an investment of USD 8 million in the healthcare company Siren.

Siren aims to reduce the risk of diabetic foot ulcers through early detection of potential damage using temperature-sensing textile technology used in socks.

"Our strategic investment in Siren reflects our commitment to integrate into digital ecosystems and develop innovative digital solutions that revolutionize healthcare," said Mölnlycke CEO Zlatko Rihter.